U.S. Markets close in 2 hrs 13 mins

CollPlant Biotechnologies Ltd. (CLGN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
13.57-0.43 (-3.07%)
As of 1:20PM EDT. Market open.

CollPlant Biotechnologies Ltd.

Weizmann Science Park
4 Oppenheimer
Rehovot 7670104
972 73 232 5600

Full Time Employees52

Key Executives

NameTitlePayExercisedYear Born
Mr. Yehiel TalChief Exec. Officer595kN/A1952
Mr. Eran Rotem CPADeputy CEO & CFO451kN/A1968
Dr. Ilana BelzerChief Operations Officer270kN/A1960
Prof. Oded ShoseyovFounder & Chief ScientistN/AN/A1956
Ms. Hadas Dreiher HorowitzVP of HRN/AN/A1977
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bio-printing of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. The company's products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. Its products include BioInks for 3D printing of tissues and organs; dermal filler for treating wrinkles; 3D Bioprinted breast implants that are used for the regeneration of breast tissue; injectable implants to promote breast tissue regeneration; VergenixSTR, a soft tissue repair matrix intended for treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.

Corporate Governance

CollPlant Biotechnologies Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.